$300M Series D funding secured & Dr. Omar Ishrak appointed Biofourmis Chairman Learn More
Biofourmis provides end-to-end Care@Home solutions, including:
Complete the form to arrange a demo and see how our FDA-cleared algorithms power personalized, predictive care.